The Prescription Drugs (Pharmacies) market in Myanmar has been experiencing significant growth in recent years, driven by various factors such as increasing healthcare expenditure and a growing demand for quality healthcare services. Customer preferences in the Prescription Drugs (Pharmacies) market in Myanmar are influenced by several factors. Firstly, there is a growing awareness among the population about the importance of healthcare and the need for prescription drugs to treat various medical conditions. This has led to an increase in the demand for prescription drugs in the country. Additionally, customers in Myanmar are becoming more conscious about the quality and safety of the drugs they purchase, leading to a preference for pharmacies that offer genuine and reliable products. Trends in the Prescription Drugs (Pharmacies) market in Myanmar indicate a shift towards modernization and digitization. Pharmacies in the country are increasingly adopting technology to streamline their operations and improve customer experience. This includes the use of electronic health records, online ordering systems, and home delivery services. These trends are driven by the need to provide convenient and efficient services to customers, as well as to keep up with global advancements in the healthcare industry. Local special circumstances in Myanmar have also contributed to the development of the Prescription Drugs (Pharmacies) market. The country has been undergoing significant political and economic reforms in recent years, leading to an increase in foreign investment and the establishment of international healthcare companies. This has resulted in the entry of new players in the market, bringing in advanced healthcare technologies and practices. Additionally, the government has been actively promoting the development of the healthcare sector, including the expansion of healthcare infrastructure and the implementation of healthcare reforms. These initiatives have created a conducive environment for the growth of the Prescription Drugs (Pharmacies) market in Myanmar. Underlying macroeconomic factors, such as the country's economic growth and rising disposable incomes, have also contributed to the development of the Prescription Drugs (Pharmacies) market in Myanmar. As the country's economy continues to grow, more people have the financial means to afford prescription drugs and are willing to spend on healthcare services. This has created a lucrative market for pharmacies in the country. Furthermore, the government's increased healthcare expenditure and focus on improving healthcare access and quality have also supported the growth of the Prescription Drugs (Pharmacies) market. Overall, the Prescription Drugs (Pharmacies) market in Myanmar is experiencing significant growth, driven by increasing healthcare expenditure, customer preferences for quality and reliable drugs, and the adoption of technology in the sector. The local special circumstances, such as political and economic reforms, and the government's focus on healthcare development, have also contributed to the growth of the market. With the continued economic growth and government support, the Prescription Drugs (Pharmacies) market in Myanmar is expected to further expand in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
